Fidelity Investments’s Journey Medical DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.57K Sell
376
-100
-21% -$697 ﹤0.01% 5185
2026
Q2
$3.37K Sell
476
-1,718
-78% -$9.8K ﹤0.01% 5088
2026
Q1
$10.3K Buy
2,194
+1,998
+1,019% +$15.5K ﹤0.01% 4760
2025
Q4
$1.51K Buy
196
+177
+932% +$1.39K ﹤0.01% 5050
2025
Q3
$135 Buy
+19
New +$138 ﹤0.01% 5182
2025
Q2
– Sell
-2
Closed -$13 – 5360
2025
Q1
$13 Buy
+2
New +$10 ﹤0.01% 5239
2024
Q1
– Sell
-128
Closed -$734 – 5425
2023
Q4
$734 Buy
+128
New +$570 ﹤0.01% 4786

Other funds holding DERM

Fidelity Investments's DERM Position: Q3 2026 in Review

Fidelity Investments reduced its Journey Medical (DERM) stake by 21% in Q3 2026, selling an estimated $697 and leaving 376 shares worth $2.57K. The position accounts for ﹤0.01% of the portfolio, ranked #5185.

Fidelity Investments first reported a position in DERM in Q4 2023 and has held it in 7 quarters since. The position peaked at $10.3K in Q1 2026. 74 funds tracked by Wall St. Rank hold DERM as of Q3 2026.

  • Fidelity Investments held 376 shares of Journey Medical worth $2.57K as of Q3 2026.
  • Fidelity Investments sold 100 Journey Medical shares in Q3 2026, an estimated $697.
  • Journey Medical made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #5185 holding.
  • Fidelity Investments first reported a position in Journey Medical in Q4 2023 and has held it in 7 quarters since.
  • Fidelity Investments's Journey Medical position peaked at $10.3K in Q1 2026.
  • 74 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.